Please login to the form below

Not currently logged in
Email:
Password:

Roche nominates Dr Claudia Süssmuth Dyckerhoff to board

She is set to replace Professor Dr Beatrice Weder di Mauro

Roche - Basel, SwitzerlandRoche's board of directors have lined up Dr Claudia Süssmuth Dyckerhoff to replace Professor Dr Beatrice Weder di Mauro, who has decided to not stand for re-election at the company's annual general meeting in March.

Weder di Mauro has been a member of the board since 2006 and also served on its audit committee.

Dyckerhoff is currently senior partner at McKinsey & Company and sector leader Asia health services and systems.

Christoph Franz, chairman of Roche, said: “As a member of the board and the audit committee, Beatrice Weder di Mauro has made significant contributions to Roche's success with her broad expertise in economics.”

He added: “I am delighted with our nomination of Claudia Süssmuth Dyckerhoff for election as a new member of the board. She is a leader with extensive international experience in strategic consultancy in the healthcare industry, especially in Asian growth markets.”

7th January 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics